EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting Mitochondrial Metabolic Dysfunction in Pulmonary Hypertension: Toward New Therapeutic Approaches?

Marianne Riou, Irina Enache, François Sauer, Anne-Laure Charles iD, Bernard Geny

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24119572 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Marianne Riou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Translational Medicine Federation of Strasbourg (FMTS), CRBS, University of Strasbourg, Team 3072 "Mitochondria, Oxidative Stress and Muscle Protecti…. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Pulmonary Arterial Hypertension. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary arterial hypertension (PAH) is a rare disease characterized by pulmonary vascular remodeling leading to right heart failure and death. To date, despite the three therapeutic approaches targeting the three major endothelial dysfunction pathways based on the prostacyclin, nitric oxide/cyclic guanosine monophosphate, and endothelin pathways, PAH remains a serious disease. As such, new targets and therapeutic agents are needed. Mitochondrial metabolic dysfunction is one of the mechanisms involved in PAH pathogenesis in part through the induction of a Warburg metabolic state of enhanced glycolysis but also through the upregulation of glutaminolysis, tricarboxylic cycle and electron transport chain dysfunction, dysregulation of fatty acid oxidation or mitochondrial dynamics alterations. The aim of this review is to shed light on the main mitochondrial metabolic pathways involved in PAH and to provide an update on the resulting interesting potential therapeutic perspectives.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypertension, PulmonaryPulmonary Arterial HypertensionHumansFamilial Primary Pulmonary HypertensionGlycolysisMitochondria

Stichwörter der Autor:innen

Warburg effectmetabolic abnormalitiesmitochondrial dysfunctionpulmonary hypertensionpulmonary vascular remodelingright ventricle

Autor:innen und Institutionen

  • Translational Medicine Federation of Strasbourg (FMTS), CRBS, University of Strasbourg, Team 3072 "Mitochondria, Oxidative Stress and Muscle Protection", 1 Rue Eugène Boeckel, CS 60026, CEDEX 67084 Strasbourg, France.
  • Physiology and Functional Exploration Unit, University Hospital of Strasbourg, 1 Place de l'Hôpital, CEDEX 67091 Strasbourg, France.
  • Cardiology Unit, University Hospital of Strasbourg, 1 Place de l'Hôpital, CEDEX 67091 Strasbourg, France.

ORCID-Profile: Anne-Laure Charles

Zitieren

APA

Riou, M., Enache, I., Sauer, F., Charles, A. L., & Geny, B. (2023). Targeting Mitochondrial Metabolic Dysfunction in Pulmonary Hypertension: Toward New Therapeutic Approaches?. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24119572

Vancouver

Riou M, Enache I, Sauer F, Charles AL, Geny B. Targeting Mitochondrial Metabolic Dysfunction in Pulmonary Hypertension: Toward New Therapeutic Approaches?. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24119572

BibTeX
@article{Riou2023,
  author = {Riou, Marianne and Enache, Irina and Sauer, François and Charles, Anne-Laure and Geny, Bernard},
  title = {Targeting Mitochondrial Metabolic Dysfunction in Pulmonary Hypertension: Toward New Therapeutic Approaches?},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24119572}
}
Kostenlos starten →